Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ProQR Therapeutics N.V.

    NASDAQ: PRQR · Real-Time Price · USD
    1.89
    -0.01 (-0.53%)
    At close: Jun 17, 2025, 3:59 PM
    1.94
    2.65%
    After-hours: Jun 17, 2025, 07:06 PM EDT

    ProQR Therapeutics Statistics

    Share Statistics

    ProQR Therapeutics has 105.21M shares outstanding. The number of shares has increased by 28.84% in one year.

    Shares Outstanding

    n/a
    		 105.21M

    Shares Change (YoY)

    n/a
    		 28.84%

    Shares Change (QoQ)

    n/a
    		 1.95%

    Owned by Institutions (%)

    n/a
    		 54.38%

    Shares Floating

    n/a
    		 72.22M

    Failed to Deliver (FTD) Shares

    n/a
    		 384,795

    FTD / Avg. Volume

    n/a
    		 69.22%

    Short Selling Information

    The latest short interest is 584.15K, so 0.55% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 584.15K

    Short % of Shares Out

    n/a
    		 0.55%

    Short % of Float

    n/a
    		 0.71%

    Short Ratio (days to cover)

    n/a
    		 1.66

    Valuation Ratios

    The PE ratio is -7.53 and the forward PE ratio is -3.48. ProQR Therapeutics's PEG ratio is 2.63.

    PE Ratio

    n/a
    		 -7.53

    Forward PE

    n/a
    		 -3.48

    PS Ratio

    n/a
    		 11.05

    Forward PS

    n/a
    		 1.4

    PB Ratio

    n/a
    		 2.36

    P/FCF Ratio

    n/a
    		 -5.53

    PEG Ratio

    n/a
    		 2.63
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ProQR Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.95, with a Debt / Equity ratio of 0.19.

    Current Ratio

    n/a
    		 3.95

    Quick Ratio

    n/a
    		 3.95

    Debt / Equity

    n/a
    		 0.19

    Debt / EBITDA

    n/a
    		 -0.71

    Debt / FCF

    n/a
    		 -0.46

    Interest Coverage

    n/a
    		 -28.29

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $113,885.54

    Profits Per Employee

    n/a
    		 $-167,246.99

    Employee Count

    n/a
    		 166

    Asset Turnover

    n/a
    		 0.11

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -197K

    Effective Tax Rate

    n/a
    		 0.7%

    Stock Price Statistics

    The stock price has increased by 11.76% in the last 52 weeks. The beta is 0.31, so ProQR Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.31

    52-Week Price Change

    n/a
    		 11.76%

    50-Day Moving Average

    n/a
    		 1.58

    200-Day Moving Average

    n/a
    		 2.28

    Relative Strength Index (RSI)

    n/a
    		 59.73

    Average Volume (20 Days)

    n/a
    		 555,907

    Income Statement

    In the last 12 months, ProQR Therapeutics had revenue of 18.91M and earned -27.76M in profits. Earnings per share was -0.34.

    Revenue

    n/a
    		 18.91M

    Gross Profit

    n/a
    		 18.91M

    Operating Income

    n/a
    		 -30.47M

    Net Income

    n/a
    		 -27.76M

    EBITDA

    n/a
    		 -24.12M

    EBIT

    n/a
    		 -26.88M

    Earnings Per Share (EPS)

    n/a
    		 -0.34
    Full Income Statement

    Balance Sheet

    The company has 149.41M in cash and 17.22M in debt, giving a net cash position of 132.19M.

    Cash & Cash Equivalents

    n/a
    		 149.41M

    Total Debt

    n/a
    		 17.22M

    Net Cash

    n/a
    		 132.19M

    Retained Earnings

    n/a
    		 -427.16M

    Total Assets

    n/a
    		 151.69M

    Working Capital

    n/a
    		 104.36M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -36.39M and capital expenditures -1.42M, giving a free cash flow of -37.81M.

    Operating Cash Flow

    n/a
    		 -36.39M

    Capital Expenditures

    n/a
    		 -1.42M

    Free Cash Flow

    n/a
    		 -37.81M

    FCF Per Share

    n/a
    		 -0.46
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -161.18% and -146.86%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -161.18%

    Pretax Margin

    n/a
    		 -147.9%

    Profit Margin

    n/a
    		 -146.86%

    EBITDA Margin

    n/a
    		 -127.6%

    EBIT Margin

    n/a
    		 -161.18%

    FCF Margin

    n/a
    		 -200.01%

    Dividends & Yields

    PRQR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PRQR is $9, which is 373.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 373.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -2.22

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist